Evaluation of Efficacy and Safety of THRV-1268 in Long QT Syndrome Type 2 (LQTS 2)
NCT07277582
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
RECRUITING
Status
64
Enrollment
INDUSTRY
Sponsor class
Conditions
Long QT Syndrome (LQTS) 2
Interventions
OTHER:
baseline lead-in
DRUG:
THRV-1268
DRUG:
THRV-1268
Sponsor
Thryv Therapeutics, Inc.